Skip to content

Psorcast Mobile Study

Psorcast Study: A Smartphone-based Study of Psoriasis and Psoriatic Arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05621369
Enrollment
1000
Registered
2022-11-18
Start date
2022-01-01
Completion date
2027-01-31
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dactylitis, Dermatologic Disease, Joint Pain, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Psoriatic Conditions, Psoriatic Nail, Rheumatologic Disease

Keywords

Psoriasis, Psoriatic Arthritis, Psoriatic Disease, Health app research, mHealth research, Mobile health research

Brief summary

The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

Detailed description

Psoriatic disease exhibits a spectrum of symptoms and can transition from psoriasis (PsO), largely affecting the skin, to psoriatic arthritis (PsA) involving widespread musculoskeletal inflammation. Early detection of the PsO-to-PsA transition and rapid administration of effective treatment is essential, as a delay in diagnosing PsA by as little as 6 months can lead to irreversible joint damage. This "ticking clock" paradigm drives the need for frequent monitoring and effective therapeutic intervention as early as possible to attenuate or possibly prevent disease progression. Using a suite of smartphone-based measurements in an app called Psorcast (psoriasis forecasts), we aim to aggregate weekly, symptom measurements from participants in a remote, longitudinal observational study to map the trajectories of treatment response and disease progression. In this study, we will explore measurements of psoriatic disease activity at least an order of magnitude more frequently (weekly vs. quarterly) than standard clinical practice or clinical trial designs. This study is not meant to provide a medical diagnosis, treatment, or medical advice. It is meant to provide a scalable, inexpensive, non-invasive and frequent measure and tracking of psoriasis and psoriatic arthritis for research purposes.

Interventions

At enrollment, participants are asked to complete a baseline health history, family history, and a participant-reported symptom inventory.

BEHAVIORALPsoriasis Draw

Participants are asked to draw the location and size of psoriasis they currently experience. Participants are provided a body template onto which they can draw on their screen. Investigators estimate the percentage of body area affected.

BEHAVIORALPsoriasis Area Photo

Participants are asked to take a picture of a representative psoriasis plaque and indicate the location of the plaque. They are asked to take a picture of the same area over time. The investigators are developing computer vision algorithms to assess the plaque.

BEHAVIORALFinger and Toe Photos

Participants are asked to take pictures of the back of each hand and the top of each foot. These photos can be used to assess finger and toe swelling as well as psoriatic nail involvement. The investigators are developing computer vision algorithms to assess psoriatic nail involvement and digit swelling.

BEHAVIORALDigital Jar Open

Participants are asked to internally and externally rotate the phone as it rests on a flat surface. Participants perform each direction (internal and external) and each arm (left and right) in turn. Gyroscope sensors measure the degree of rotation.

BEHAVIORAL30 Second Walk

Participants are asked to walk in a straight line for 30 seconds. Gait is measured by gyroscope and accelerometer sensors. The investigators examine step-dependent and sequence-dependent features from these sensors. The investigators apply feature selection and classifier algorithms to analyze these data.

OTHERPsorcast mobile application

Participants complete all described behavioral interventions via a dedicated iPhone app, Psorcast.

Sponsors

Sage Bionetworks
Lead SponsorOTHER
Brigham and Women's Hospital
CollaboratorOTHER
NYU Langone Health
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
Harvard Medical School (HMS and HSDM)
CollaboratorOTHER
New York University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult age 18 and older who consent to participate in the study * Own a compatible iPhone or iPod Touch device running iOS 12.2 or above * Be able to read and understand an official language of the country of participation

Exclusion criteria

* Age 17 years or younger * Not a resident of the a country where the app is approved for use * Not have a personal (i.e., not shared) iPhone (4s or newer running iOS 8.0 or later) * Not be able to read and understand an official language of the country of participation

Design outcomes

Primary

MeasureTime frameDescription
Results of participant self-assessment surveysThrough study completion, an average of 2 yearsResults of participant self-assessment surveys will be analyzed using descriptive statistics. These results may also be compared with other intervention results.
Body surface area and location from the Psoriasis Draw assessmentThrough study completion, an average of 2 yearsThe investigators will quantify body surface area and psoriasis area hotspots across the cohort. These results may also be compared with other intervention results.
Computer vision features from Psoriasis Area Photo assessmentThrough study completion, an average of 2 yearsThe investigators apply visual processing and classifier algorithms to analyze the images from the Psoriasis Area Photo assessments. These results may also be compared with other intervention results.
Computer vision features from Finger/Toe PhotosThrough study completion, an average of 2 yearsThe investigators apply visual processing and classifier algorithms to segment nails and joints from hand and foot photos. These results may also be compared with other intervention results.
Gyroscope and accelerometer sensor measurements from Digital Jar Open assessmentThrough study completion, an average of 2 yearsThe investigators examine rotational features from gyroscope and accelerometer sensors. The investigators apply feature selection and classifier algorithms to analyze these data. These results may also be compared with other intervention results.
Gyroscope and accelerometer sensor measurements from 30-sec Walk assessmentThrough study completion, an average of 2 yearsThe investigators examine step-dependent and sequence-dependent features from gyroscope and accelerometer sensors. The investigators apply feature selection and classifier algorithms to analyze these data. These results may also be compared with other intervention results.
Quantification and distribution of self-reported painful jointsThrough study completion, an average of 2 yearsThe investigators will quantify the self-reported painful joints and, in particular, compare to measurements from the 30-sec Walk and Digital Jar Open to identify correlations. These results may also be compared with other intervention results.

Secondary

MeasureTime frameDescription
App usage data for assessment of participant engagementThrough study completion, an average of 2 yearsApp usage data is used to gauge participant engagement throughout the study period. These results may also be compared with other intervention results.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSolveig Sieberts, Ph.D

Sage Bionetworks

PRINCIPAL_INVESTIGATORJose Scher, MD

NYU Langone Medical Center

PRINCIPAL_INVESTIGATORJoseph Merola, MD, MMSc

Brigham and Women's Hospital & Harvard Medical School

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026